Cross-sensitivity reaction between tacrolimus and macrolide antibiotics

Bone Marrow Transplantation

Volumn 25, Issue 8, 2000, Pages 907-908

  Riley, L ^a   Mudd, L ^a   Baize, T ^a   Herzig, R ^a  

^a UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

Allergy; Macrolide; Tacrolimus

Indexed keywords

ALLOPURINOL; ALPRAZOLAM; CIPROFLOXACIN; CLARITHROMYCIN; CONJUGATED ESTROGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTOMEGALOVIRUS ANTIBODY; FAMOTIDINE; FLUCONAZOLE; MACROLIDE; METHYLPREDNISOLONE; SULFAMETHOXAZOLE; TACROLIMUS; THYMOCYTE ANTIBODY; TRIMETHOPRIM; URSODEOXYCHOLIC ACID; VANCOMYCIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; CASE REPORT; CROSS ALLERGY; DRUG ERUPTION; DRUG HYPERSENSITIVITY; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; PRIORITY JOURNAL; PRURITUS; WHOLE BODY RADIATION;

EID: 0034119182     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702223     Document Type: Article

References (4)

1. Asante-Korang A, Boyle GJ, Webber S et al. Experience of FK 506 immune suppression in pediatric heart transplantation: a study of long-term adverse effects. J Heart Lung Transplant 1996; 15: 415-422.
2. Young L, Koda-Kimble MA. Applied Therapeutics: the Clinical Use of Drugs. Applied Therapeutics: Vancouver, 1996, Section 33, pp 7-8.
3. Facts and Comparisons. Wolters Kluwer: St Louis, MO, 1999, 342g-344b.
4. Package insert. Prograf (tacrolimus). Fujisawa USA, Inc. Deerfield, IL.